A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections by administering fatty acid based compositions. The present invention further provides a free fatty acid based sprayable composition to prevent and/or treatment of SARS-Virus related infections. The fatty acids used in the present invention are Linoleic acid (LA), α-linolenic acid (ALA) and gamma-linolenic acid (GLA). In a preferred embodiment, we propose that topical administration of naturally occurring fatty acids in an optimal formulation may be beneficial in the prophylaxis of respiratory enveloped viruses and in particular the lipid-rich SARS-CoV-2 virus. This could be administered via nasal and/or oral route. The composition comprises at least one fatty acid, a suitable carrier, preservative, cosolvents and surfactants and/or cyclodextrin used as an excipient that may also enhance anti-viral properties.

A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections by administering fatty acid based compositions. The present invention further provides a free fatty acid based sprayable composition to prevent and/or treatment of SARS-Virus related infections. The fatty acids used in the present invention are Linoleic acid (LA), α-linolenic acid (ALA) and gamma-linolenic acid (GLA). In a preferred embodiment, we propose that topical administration of naturally occurring fatty acids in an optimal formulation may be beneficial in the prophylaxis of respiratory enveloped viruses and in particular the lipid-rich SARS-CoV-2 virus. This could be administered via nasal and/or oral route. The composition comprises at least one fatty acid, a suitable carrier, preservative, cosolvents and surfactants and/or cyclodextrin used as an excipient that may also enhance anti-viral properties.

A stabilized active oxygen-generating antiseptic composition is disclosed including at least one of an antiseptic mixture or an antiseptic polymer. The antiseptic mixture includes a persulfate distributed in a matrix of a sulfate wherein the antiseptic composition is characterized by a ratio of the sulfate to the persulfate of at least 8:2. The antiseptic polymer is formed by the reaction of a sulfate, a persulfate, and amino acid in a reaction solution having a ratio of the sulfate to the persulfate of at least 6:4 and a ratio of the amino acid to the sulfate and the persulfate combined of 1:2 to 2:1. An antiseptic irrigation solution is disclosed including the antiseptic composition dispersed in a solvent. An antiseptic article is disclosed including an article and at least one of the antiseptic composition or an antiseptic coating formed from the antiseptic composition disposed on a surface of the article.

This invention relates generally to methods of preparing compositions from microorganisms such as cyanobacteria, particularly to preparing compositions with antifungal and/or antibacterial characteristics, and more particularly to preparing cyanobacteria or other microorganism-derived compositions for use in construction materials. Cyanobacteria make various kinds of natural products that may be useful for a variety of applications, including products with antifungal and/or antibacterial activity, and other biologically active compounds (e.g. immunomodulatory, antitumor, antithrombotic, anticoagulant, anti-mutagenic, anti-inflammatory, antimicrobial, and antiviral). Some of the especially useful ones might be antifungals and antibacterials, such as by incorporation or application onto construction materials (e.g. drywall).

This invention relates generally to methods of preparing compositions from microorganisms such as cyanobacteria, particularly to preparing compositions with antifungal and/or antibacterial characteristics, and more particularly to preparing cyanobacteria or other microorganism-derived compositions for use in construction materials. Cyanobacteria make various kinds of natural products that may be useful for a variety of applications, including products with antifungal and/or antibacterial activity, and other biologically active compounds (e.g. immunomodulatory, antitumor, antithrombotic, anticoagulant, anti-mutagenic, anti-inflammatory, antimicrobial, and antiviral). Some of the especially useful ones might be antifungals and antibacterials, such as by incorporation or application onto construction materials (e.g. drywall).

The present disclosure discloses a Streptomyces antioxidans strain Sa-21, namely, strain Sa-21 with an accession number of CCTCC NO: M 2020423. The present disclosure also discloses the use of the aforementioned Strepiomyces antioxidans strain Sa-21 in inhibition of Alternaria solani (A. solani). The Streptomyces antioxidans strain also has an inhibiting effect on both plant pathogenic fungi and plant pathogenic bacteria.

The present disclosure discloses a Streptomyces antioxidans strain Sa-21, namely, strain Sa-21 with an accession number of CCTCC NO: M 2020423. The present disclosure also discloses the use of the aforementioned Strepiomyces antioxidans strain Sa-21 in inhibition of Alternaria solani (A. solani). The Streptomyces antioxidans strain also has an inhibiting effect on both plant pathogenic fungi and plant pathogenic bacteria.

An antiseptic composition for use as a topical skin sanitizer or as a surface disinfectant includes Populus tremuloides Bark Extract and/or Ribes Nigum Fruit Extract in an amount of from about 0.1 to about 50 weight percent effective as a broad spectrum antiseptic and antimicrobial agent. The composition includes an aqueous medium and/or one or more oils. The amount of the aqueous medium is from 45 to about 95 weight percent. The amount of oils is from 0.03 to about 50 weight percent. The composition may also include up to about 1 weight percent of one or more soothing agents; up to about 5 weight percent of one or more thickeners; and up to about 38 weight percent of one or more emulsifiers. The composition does not contain alcohols, chlorinated compounds, iodine, or phenols.

The disclosure relates to a microbicidal composition with excellent action of limiting a decrease in durability of synthetic adhesives as well as high microbicidal action. The microbicidal composition contains 0.03 to less than 1.0 mass % of peracetic acid, 0.045 to less than 1.5 mass % of hydrogen peroxide, and 0.036 mass % or more of glycine.

The disclosure relates to a microbicidal composition with excellent action of limiting a decrease in durability of synthetic adhesives as well as high microbicidal action. The microbicidal composition contains 0.03 to less than 1.0 mass % of peracetic acid, 0.045 to less than 1.5 mass % of hydrogen peroxide, and 0.036 mass % or more of glycine.